rdf:type |
|
lifeskim:mentions |
umls-concept:C0017797,
umls-concept:C0026809,
umls-concept:C0027882,
umls-concept:C0205314,
umls-concept:C0376315,
umls-concept:C0439536,
umls-concept:C0475264,
umls-concept:C0521447,
umls-concept:C0679622,
umls-concept:C1185740,
umls-concept:C1415504,
umls-concept:C1517676,
umls-concept:C1524003
|
pubmed:issue |
4
|
pubmed:dateCreated |
2000-4-14
|
pubmed:abstractText |
Huntington's disease (HD) is caused by an expanded N-terminal glutamine tract that endows huntingtin with a striatal-selective structural property ultimately toxic to medium spiny neurons. In precise genetic models of juvenile HD, HdhQ92 and HdhQ111 knock-in mice, long polyglutamine segments change huntingtin's physical properties, producing HD-like in vivo correlates in the striatum, including nuclear localization of a version of the full-length protein predominant in medium spiny neurons, and subsequent formation of N-terminal inclusions and insoluble aggregate. These changes show glutamine length dependence and dominant inheritance with recruitment of wild-type protein, critical features of the altered HD property that strongly implicate them in the HD disease process and that suggest alternative pathogenic scenarios: the effect of the glutamine tract may act by altering interaction with a critical cellular constituent or by depleting a form of huntingtin essential to medium spiny striatal neurons.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0964-6906
|
pubmed:author |
pubmed-author:AuerbachWW,
pubmed-author:GusellaJ FJF,
pubmed-author:GutekunstC ACA,
pubmed-author:HerschSS,
pubmed-author:JoynerA LAL,
pubmed-author:LiS HSH,
pubmed-author:LiX JXJ,
pubmed-author:MacDonaldM EME,
pubmed-author:VonsattelJ PJP,
pubmed-author:VrbanacVV,
pubmed-author:WeaverMM,
pubmed-author:WheelerV CVC,
pubmed-author:WhiteJ KJK,
pubmed-author:YuDD
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-13
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10699173-Animals,
pubmed-meshheading:10699173-Cell Nucleus,
pubmed-meshheading:10699173-Corpus Striatum,
pubmed-meshheading:10699173-Cytoplasm,
pubmed-meshheading:10699173-Glutamine,
pubmed-meshheading:10699173-Huntington Disease,
pubmed-meshheading:10699173-Immune Sera,
pubmed-meshheading:10699173-Inclusion Bodies,
pubmed-meshheading:10699173-Mice,
pubmed-meshheading:10699173-Mice, Mutant Strains,
pubmed-meshheading:10699173-Mutagenesis, Insertional,
pubmed-meshheading:10699173-Nerve Tissue Proteins,
pubmed-meshheading:10699173-Neurons,
pubmed-meshheading:10699173-Nuclear Proteins,
pubmed-meshheading:10699173-Peptides,
pubmed-meshheading:10699173-Phenotype,
pubmed-meshheading:10699173-Solubility
|
pubmed:year |
2000
|
pubmed:articleTitle |
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.
|
pubmed:affiliation |
Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|